Although no statistically significant intergroup differences were identified, the figure illustrates a mild trend toward a higher proportion of excellent functional outcomes (mRS 0–1) in the dual antiplatelet therapy group between DM and non-DM patients.
← all excerpts
Diabetes mellitus and efficacy of dual antiplatelet in acute ischemic stroke: A post hoc analysis of the ATAMIS trial.
2
—
—
The sentences
Since the interaction analysis did not reach statistical significance, the evidence is insufficient to conclude that the treatment effect differs meaningfully between the DM and non-DM subgroups.